Feasibility, acceptability and safety of personalized adaptive enzalutamide therapy in people with metastatic castrate-resistant prostate cancer (mCRPC): EnzAdapt
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要